HilleVax Q2 2024 GAAP EPS $(0.83) Misses $(0.43) Estimate
Portfolio Pulse from Benzinga Newsdesk
HilleVax (NASDAQ:HLVX) reported a Q2 2024 GAAP EPS of $(0.83), missing the analyst consensus estimate of $(0.43) by 93.02%. This represents a 12.16% increase in losses compared to the same period last year. The company has $245.0 million in cash, cash equivalents, and marketable securities as of June 30, 2024.
August 09, 2024 | 5:57 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HilleVax reported a Q2 2024 GAAP EPS of $(0.83), missing the analyst consensus estimate of $(0.43) by 93.02%. This represents a 12.16% increase in losses compared to the same period last year. The company has $245.0 million in cash, cash equivalents, and marketable securities as of June 30, 2024.
The significant miss on earnings estimates and the increase in losses compared to the previous year are likely to negatively impact investor sentiment and the stock price in the short term. However, the company's substantial cash reserves may provide some cushion.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100